MapLight Therapeutics, Inc. (MPLT) Misses Q2 EPS by 33c
Tweet
Share
E-mailGet Alerts MPLT Hot Sheet
Join SI Premium – FREE
MapLight Therapeutics, Inc. (NASDAQ: MPLT) reported Q2 EPS of ($1.32), $0.33 worse than the analyst estimate of ($0.99).
For earnings history and earnings-related data on MapLight Therapeutics, Inc. (MPLT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fox upgraded to overweight as Roku deal, ad strength lift outlook
- Evolv Technology adds 70 customers in Q2, expands bag screening
- Star Equity to acquire Harte Hanks for $5.00 per share
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
